Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 748.7 M756.77 M788.55 M792.12 M 3.09 B Research & development ———— — Operating income 617.86 M655.71 M659.9 M673.03 M 2.61 B Non-Operating Income, Total 2.21 M866 K805 K1.23 M 5.11 M Interest expense, net of interest capitalized 24.16 M28.08 M28.21 M25.84 M 106.28 M Non-Operating Income, excl. Interest Expenses -21.95 M-27.21 M-27.41 M-24.61 M -101.18 M Unusual income/expense ———— — Pretax income 595.91 M628.5 M632.5 M648.43 M 2.51 B Equity in earnings ———— — Taxes 104.77 M133.16 M130 M137.44 M 505.37 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 491.14 M495.34 M502.5 M510.99 M 2 B Discontinued operations ———— — Net income 491.14 M495.34 M502.5 M510.99 M 2 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 489.49 M493.74 M500.9 M509.53 M 1.99 B Basic earnings per share (Basic EPS) 1.211.231.251.28 4.97 Diluted earnings per share (Diluted EPS) 1.21.211.244.55 4.91 Average basic shares outstanding 403.29 M401.48 M400.04 M401.27 M — Diluted shares outstanding 409.29 M406.43 M404.72 M406.2 M — EBITDA 701.6 M699.72 M663.57 M— — EBIT 575.66 M614.41 M618.4 M— — Cost of revenue 1.35 B1.39 B1.39 B1.42 B 5.56 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 125.94 M127.5 M128.67 M130.74 M 512.85 M